Harper L, Morgan MD, Walsh M, et al. (2012. June). „Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.” (angol nyelven). Ann Rheum Dis.71 (6), 955-60. o. DOI:10.1136/annrheumdis-2011-200477. PMID22128076.
Petri M, Brodsky RA, Jones RJ, et al. (2010. May). „High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.” (angol nyelven). Arthritis Rheum.62 (5), 1487-93. o. DOI:10.1002/art.27371. PMID20131296.
nih.gov
pubmed.ncbi.nlm.nih.gov
Ahmed AR, Hombal SM. (1984. December). „Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses.” (angol nyelven). J Am Acad Dermatol.11 (6), 1115-26. o. PMID6392368.
Roy P, Waxman DJ. (2006. March). „Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.” (angol nyelven). Toxicol In Vitro.20 (2), 176-86. o. PMID16293390.
Harper L, Morgan MD, Walsh M, et al. (2012. June). „Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.” (angol nyelven). Ann Rheum Dis.71 (6), 955-60. o. DOI:10.1136/annrheumdis-2011-200477. PMID22128076.
Petri M, Brodsky RA, Jones RJ, et al. (2010. May). „High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.” (angol nyelven). Arthritis Rheum.62 (5), 1487-93. o. DOI:10.1002/art.27371. PMID20131296.
Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. (1989. August). „Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.” (angol nyelven). Cancer.64 (3), 629-34. o. PMID2743258.
Korkmaz A, Topal T, Oter S. (2007. September). „Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.” (angol nyelven). Cell Biol Toxicol.23 (5), 303-12. o. PMID17225077.